High Efficacy and Low Toxicity of MB-106, a Third Generation CD20 Targeted CAR-T for Treatment of Relapsed/Refractory B-NHL and CLL

Authors :: Mazyar Shadman
Cecilia CS Yeung
Mary Redman
Sang Yun Lee
Dong Hoon Lee
Susan Ra
Chaitra S Ujjani
Bruce J Dezube
Christina Poh
Edus H. Warren
Aude G. Chapuis
Damian J. Green
Andrew J. Cowan
Ryan D. Cassaday
Hans-Peter Kiem
Jordan Gauthier
Cameron J. Turtle
Ryan C. Lynch
Stephen D. Smith
Ajay K. Gopal
David G. Maloney
Brian G. Till
Source :: Transplantation and Cellular Therapy. 28:S182-S183
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Subjects :: Transplantation
Molecular Medicine
Immunology and Allergy
Cell Biology
Hematology

Tools